CHEK2 and ovarian cancer: For example, the American Society of Breast Surgeons recently recommended that any patient with a personal history of breast cancer should receive genetic testing with a gene panel containing ATM, CHEK2, PALB2, and other DDR genes that are known to be associated with an increased risk of breast and ovarian cancer [38].